Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19) by T. I. Smolyanova, N. S. Bagaeva, M. A. Kolganova, I. E. Shohin, A. M. Nikolaeva, T. V. Vyaznikova, A. A. Pankratova, E. A. Bykova

Get full text

Determination of optimum nanofiltration conditions for the manufacturing process of human normal immunoglobulin G for intravenous administration by N. V. Zubkova, A. M. Nikolaeva, A. V. Ivanov, O. V. Beliakova, M. V. Razumikhin, N. V. Vinokurova, I. S. Efimova, T. I. Smolyanova, E. I. Sakanyan

Get full text

Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin by A. M. Nikolaeva, A. V. Ivanov, T. I. Smolyanova, M. V. Razumikhin, O. V. Belyakova, E. G. Shilova, N. R. Selezneva, T. V. Vyaznikova, A. I. Semicheva, E. I. Sakanyan

Get full text